Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.

Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.

Press ReleaseIB Communicationsbracco@ibcomms.agency Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation TechnologiesTechnology based on Bracco’s clinically validated ...

The MarketWatch News Department was not involved in the creation of this content. ANN ARBOR, Mich., Jan. 8, 2026 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant microbubble cell ...

DALLAS, Jan. 21, 2025 /PRNewswire/ -- Akadeum Life Sciences(R)' successful early access program for the Alerion(TM) Microbubble Cell Separation System confirmed the Alerion(TM) to be the highest ...

Akadeum's microbubble-based cell isolation workflow addresses critical bottlenecks in cell therapy manufacturing by providing a scalable, gentle, and fully closed GMP solution for cell separation.

TORONTO, Sept. 19, 2024 /PRNewswire/ - Bracco Imaging S.A., a global leader in diagnostic imaging, and Arrayus Technologies Inc., a medical device company committed to advancing novel cancer ...